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Background: Cancer is responsible for 7.6 million deaths worldwide and surgery is the primary modality
of a curative outcome. Postoperative care is of considerable importance and it is against this backdrop
that a questionnaire based study assessing the attitudes of surgeons to monitoring postoperative sys-
temic inflammation was carried out.
Method: A Web based survey including 10 questions on the “attitudes of surgeons to the use of post-
operative markers of the systemic inflammatory response following elective surgery” was distributed via
email. Two cohorts were approached to participate in the survey. Cohort 1 consisted of 1092 surgeons on
the “Association of Coloproctology of Great Britain and Ireland (ACPGBI)” membership list. Cohort 2
consisted of 270 surgeons who had published in this field in the past as identified by two recent reviews.
A reminder email was sent out 21 days after the initial email in both cases and the survey was closed
after 42 days in both cases.
Result: In total 29 surgeons (2.7%) from cohort 1 and 40 surgeons (14.8%) from cohort 2 responded to the
survey. The majority of responders were from Europe (77%), were colorectal specialists (64%) and were
consultants (84%) and worked in teaching hospitals (54%) and used minimally invasive techniques (87%).
The majority of responders measured CRP routinely in the post-operative period (85%) and used CRP to
guide their decision making (91%) and believed that CRP monitoring should be incorporated into post-
operative guidelines (81%).
Conclusion: Although there was a limited response the majority of surgeons surveyed measure the
systemic inflammatory response following elective surgery and use CRP measurements together with
clinical findings to guide postoperative care. The present results provide a baseline against which future
surveys can be compared.
© 2017 The Author(s). Published by Elsevier Ltd on behalf of IJS Publishing Group Ltd. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Worldwide cancer remains a significant problem with 12.7
million new cases being diagnosed in 2008. Globally cancer re-
mains one of the leading causes of death and is responsible for 7.6ademic Unit of Surgery, New
arade, Glasgow, G4 0SF, UK.
olan).
ier Ltd on behalf of IJS Publishingmillion deaths per year [1,2]. In the UK each year, there are
approximately 331,000 new cases of cancer and over 50,000 deaths
each year in the 35e64 age groups. Surgery is the primary modality
of cure and therefore post-operative management is important in
cancer care [3].
Although, outcomes are predominantly determined by cancer
stage in patients with operable disease, post-operative complica-
tions are important in the disease progression [4,5]. In particular, it
has been shown that anastomotic leaks have a negative impact onGroup Ltd. This is an open access article under the CC BY-NC-ND license (http://
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[6,7]. The basis of this relationship is not clear, however it has been
proposed that themagnitude of the post-op systemic inflammatory
response [SIRS] is an important determining factor [4]. The
magnitude of this SIRS response can be routinely quantified by
serial C-reactive protein [CRP] concentration measurement in the
post-operative period [8].
Two recent meta-analyses including over 2000 patients have
reported the importance of postoperative serum CRPmeasurement
in the early diagnosis of postoperative infective complications and
anastomotic leaks in patients undergoing colorectal surgery [9,10].
Indeed, CRP thresholds have been reported as consistently pre-
dicting the development of post-operative infective complications
and may be a guide to early discharge [10e12].
However, this raises the question as to how this information
might be used in clinical practice. For example, McDermott and
coworkers [2015] have proposed that a CRP <150 mg/L on days 3, 4
and 5, be used to indicate the likelihood of safe discharge post-
operatively [11]. In a recent study in the Netherlands the use of
serial CRP monitoring has been proposed as a trigger for deter-
mining whether or not a post-operative CT should be carried out to
investigate the presence of a possible post-operative complication
[13]. Also, it has been proposed that serial CRP monitoring may be
used to determine the efficacy of ERAS protocols in the post-
operative period [8].
It is against this background that the present questionnaire
based study was carried out. The aim was to assess the attitudes of
surgeons to the use of serial post-operative CRP monitoring and its
importance in their clinical decision making. In addition, to inves-
tigate the level of awareness of the postoperative CRP thresholds
associated with the development of potential complications and to
guide clinical decision making in the postoperative period
including the decision to instigate a surgical, endoscopic or radio-
logical intervention or in discharge planning. Finally, to assess the
attitudes of surgeons to the incorporation of serial CRP monitoring
into routine postoperative care protocols and guidelines.2. Methods
Aweb based survey that included 10 questions on the “Attitudes
of surgeons to the use of postoperative markers of the systemic
inflammatory response following elective surgery” was as follows.2.1. Survey questions
1. What is your surgical specialisation? Colorectal/Oesphago-
gastric/Hepatobiliary/Urology/Thoracic/Other [please
specify]
2. In what country are you based? Open Text
3. What is your grade at present? Consultant/Trainee/Other
4. Which of the following best describes the surgical unit in
which you currently practice? University Academic Unit/
Teaching Hospital/Non-teaching Hospital/Other [please state]
5. Does your unit currently use an “enhanced recovery” or “fast
track” programme following elective surgery? yes/no
6. Do you currently perform any elective procedures using
laparoscopic, robotic or other minimally invasive tech-
niques? yes/no
7. Is C-reactive protein measured routinely in your patients
during the postoperative period following elective colorectal
surgery? yes/no
8. If you answered “Yes” to Q7: Do you currently use C-reactive
protein [CRP] to guide decision making in the postoperative
period [e.g. to trigger investigation of potentialcomplications or direct discharge]? If you answer “Yes”,
please leave specific comments to elaborate. yes/no
9. Are you aware of any existing literature examining the rela-
tionship between the magnitude of the postoperative sys-
temic inflammatory response, in particular as measured by
C-reactive protein [CRP], and outcomes following surgery? If
so, please comment. yes/no
10. Do you think that a measure of the postoperative systemic
inflammatory response, such as C-reactive protein [CRP],
should be included in postoperative care protocols or
guidelines to guide postoperative decision making and/or
discharge planning? yes/no
The survey was generated through the SurveyMonkey website
[www.surveymonkey.com/, SurveyMonkey, Palo Alto, USA] and the
access link emailed to the target cohort. The initial target cohort
included surgeons who were part of the Association of Colo-
proctology of Great Britain and Ireland (ACPGBI) mailing list
(n ¼ 1092) however responses from this were few and so a further
target cohort was selected from two recent meta-analysis [1,2] and
by performing a literature search for articles using the keywords
cancer, inflammation, CRP, postoperative care, minimal access
surgery, post-operative complications and discharge planning up to
the end of 2015 (n¼ 270). Once a comprehensive list of articles was
obtained, the email addresses of the corresponding authors from
each article formed the basis of the mailing list for distribution.
These emails were then reviewed to ascertain the specialty of the
authors to ensure that they were surgeons.
Once this was completed an email was sent out to the identified
surgeons clearly stating that the role of the study was to assess the
application of the systemic inflammatory response using CRP in the
postoperative care of patients following surgical excisions of
resectable cancers and that participation was on a voluntary basis.
Software on the website ensured duplication of response from the
same individual was not recorded. No incentives were used to
promote or encourage participation.
The initial survey to cohort 1 was distributed in November 2015
and remained open for six weeks in total. Following a literature
review the survey was sent out again to cohort 2 on 3rd June 2016
with a reminder sent out 21 days later. The survey remained open
for 3 weeks and was closed on 15th July. Data were analysed and
graphs of results were compiled using Microsoft Excel 2007 [Red-
mond, WA, USA].
3. Results
In total, 69 people completed the survey. There were 29 from
cohort 1 (2.7%) and 40 from cohort 2 (14.8%) giving an overall
response rate of 5.9%.
The response to survey question 1 is shown in Fig. 1 and 64% of
respondents were colorectal surgeons, 12% were oesophagogastric
surgeons and 14%] were hepatobiliary surgeons. The response to
question 2 is shown in Fig. 2 and 76% of respondents were from
Europe, 13% from Asia and 7% from the Americas. The response to
question 3 is shown in Fig. 3 and 84% of respondents were con-
sultants and 12% were trainee surgeons.
The response to question 4 is shown in Fig. 4 and 95% of re-
spondents worked in either a university academic unit or a teach-
ing hospital. The response to question 5 is shown in Fig. 5 and 90%
of respondents used an enhanced recovery/fast track programme
following elective surgery. The response to question 6 is shown in
Fig. 6 and 87% of respondents carried out elective surgery via
laparoscopic, robotic or another minimally invasive techniques.
The response to question 7 is shown in Fig. 7 and 85% of re-
spondents routinely used CRP in the monitoring of patients in the
Fig. 1. What is your surgical specialty? [n ¼ 68].
Fig. 2. In what region are you based? [n ¼ 68].
Fig. 3. What is your present grade? [n ¼ 68].
Fig. 4. Which of the following best describes the surgical unit in which you currently
practice? [n ¼ 68].
Fig. 5. Does your unit currently use an “enhanced recovery” or “fast track” programme
following elective surgery? [n ¼ 68].
Fig. 6. Do you currently perform any elective procedures using laparoscopic, robotic or
other minimally-invasive techniques? [n ¼ 63].
Fig. 7. Is C-reactive protein [CRP] measured routinely in your patients during the
postoperative period following elective surgery? [n ¼ 67].
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guide decision making in the post-operative period (Question 8,
Fig. 8). The response to question 9 is shown in Fig. 9 and 78% of
respondents were aware of existing literature examining the rela-
tionship between the magnitude of the postoperative systemic
inflammatory response including CRP and outcomes following
surgery.Finally, the response to question 10 is shown in Fig. 10 and 81%
of respondents considered that measures of the postoperative
Fig. 8. If you answered “yes” to Q7: Do you currently use C-reactive protein [CRP] to
guide decision making in the postoperative period [e.g. to trigger investigation of
potential complications or direct discharge]? [n ¼ 56].
Fig. 9. Are you aware of any existing literature examining the relationship between the
magnitude of the postoperative systemic inflammatory response, in particular as
measured by C-reactive protein [CRP], and outcomes following surgery? [n ¼ 67].
Fig. 10. Do you think that a measure of the postoperative systemic inflammatory
response, such as C-reactive protein [CRP], should be included in postoperative care
protocols or guidelines to guide postoperative decision making and/or discharge
planning? [n ¼ 63].
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postoperative care protocols or guidelines to guide postoperative
decision making and/or discharge planning.4. Discussion
The results of the present study showed that most respondents
were colorectal specialists, European, of consultant grade and
worked in Academic Units/Teaching Hospitals. The majority prac-
ticed enhanced recovery protocols and used markers of the sys-
temic inflammatory response (i.e. CRP) in the postoperative period
to monitor patients and guide discharge. Therefore, of those sur-
geons with an expressed interest in post-operative management of
elective surgery the majority reported that theymonitored CRP andconsidered that a measure of the post-operative systemic inflam-
matory response should be incorporated into clinical guidelines.
C-reactive protein is the prototypical marker of the systemic
inflammatory response reflecting the magnitude of injury [14]. In
the context of cancer there is concern that CRPmay also be raised in
the post-operative period as part of an immune response to the
release of tumour antigens. However, the peak operative CRP
concentrations are similar following surgery for benign or malig-
nant disease irrespective of open or laparoscopic surgery [15].
Although the majority of survey respondents were at consultant
grade it is remarkable, given that the initial reports of the clinical
utility of post-operative CRP concentrations were reported less
than a decade ago, that this group of surgeons have adopted this
measure into their routine clinical practice. This is in part due to the
simplicity of the approach and the explosion of interest in the post-
operative systemic inflammatory response. Given the survey re-
sponses in the present study, it may be problematical, perhaps
unethical, to carry out an RCT to prove the efficacy of monitoring
the systemic inflammatory response using CRP in the post-
operative period. Indeed, this approach is already part of an ERAS
protocol following elective resections in some countries [16,17].
There are a number of implications of the rapid adoption of a
CRP first approach to monitoring post-operative complications in
patients undergoing elective surgery. Firstly, there may be an
increasing requirement for CT resources to be used earlier in the
postoperative period. For example, a recent study in the
Netherlands, of 399 patients undergoing major abdominal surgery,
showed that CT imaging initiated by a combination of a deterio-
rating clinical picture and an increased CRP had a sensitivity of
91.7% and a specificity of 100% in diagnosing major complications
[18]. This study formed the basis of the PREcious trial that will
examine continuous monitoring of the postoperative inflammatory
response of days 3, 4 and 5 with the addition of a CT-scan should
the threshold of CRP > 140 mg/L be exceeded [19].
Secondly, the agreed importance of the postoperative systemic
inflammatory response opens up possible treatment options to
reduce this response and potentially postoperative complications.
For example, increased use of minimally invasive procedures such
as laparoscopic/robotic surgery has led to fewer complications [20].
Indeed, most centralised teaching centres are now carrying out
their resectional surgery using an enhanced recovery protocol with
laparoscopic/robotic techniques. There is good evidence that
minimally invasive techniques also produce less surgical stress
with a reduced postoperative systemic inflammatory response [15].
The present survey confirms that this is the direction of travel to
improve the early but safe discharge from hospital.
Also, pre-operative corticosteroids, given their proven post-
operative effect in reducing nausea and vomiting and analgesic
requirement, are frequently used in abdominal surgery [21e23].
Indeed, in two recent meta-analyses the administration of preop-
erative corticosteroids was reported to significantly reduce post-
operative complications and length of stay following abdominal
surgery [21,24]. Other pharmacological methods can also be used to
reduce the postoperative systemic inflammatory response and thus
improve outcomes. These include the use of NSAIDS, statins and H2
receptor antagonists that can reduce both the local and systemic
inflammatory responses [25].
The present study has a number of limitations. The overall
response rate was small (6%) and less than the typical response rate
of between 20 and 30% for surveys of this type. Actions known to
improve survey response rate include reduced complexity of
questions, reduced survey length, incentives, and the sending of
reminder emails [26]. In the present study the questions were
intentionally made as simple as possible and their number limited
to ten to encourage a response. A reminder email was sent several
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spondents. However, no incentive for completing the survey was
offered. In the present study there were two different cohorts.
Surgeons affiliated to the ACPGBI were selected initially as a con-
venience cohort as their members are often surveyed on aspects of
surgical care. However, the response rate was poor and a second
cohort with a known interest in the field was surveyed. The
response rate in this second cohort was higher although disap-
pointingly low. Therefore, both cohorts may have selection bias.
The former primarily due to the low response rate and the latter
primarily due to the individuals surveyed. For example, in the first
cohort interpretation of the data is difficult due to the small
number of observations. Also, in the second cohort surgeonsmainly
employed minimal access techniques. Therefore, it may be difficult
to extrapolate the results obtained to the open technique. A large
majority of respondents were from large urban teaching centres
and were individuals who have expressed an interest in this field.
While it is true that oesophagogastric and hepatobiliary resections
are now being centralised, many colonic resections are still carried
out on a regional basis. Therefore, the survey results may not reflect
practice in a general hospital setting. Although the present survey
has a number of limitations it is useful as a first approximation of
the clinical use of CRP as a post-operative tool. The present results
provide a baseline against which future surveys can be compared.
In the present survey the questions were asked in the context of
colorectal cancer since almost all work has been carried out in this
cancer. However, recent such work and the present results may also
have implications for colorectal resections in benign disease.
Further investigation is warranted in benign disease.
In summary, the present study has shown that, at least in
specialist surgical units, the majority of consultants measure the
systemic inflammatory response, using CRP, in patients following
resectional surgery. The majority use this information together
with clinical findings to instigate post-operative investigations,
guide management, and to guide discharge. It remains for this
approach to be incorporated into postoperative care guidelines/
protocols.
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